Using Biomarkers to Determine When Biopsy and When to Repeat the Biopsy- Stephen Williams

In this slide presentation, Stephen Williams details using biomarkers to determine when to biopsy and when to repeat a prostate biopsy specifically: PSA, PHI, 4K, PCA3 and Confirm MDx. He overviews the patient journey pre and post biopsy and the process of determining which patients need a rebiopsy.


Stephen B. Williams, MD Assistant Professor in Urology, Tenure-Track, Robert Earl Cone Professorship, Director of Urologic Oncology, Director of Urologic Research, Co-Director Department of Surgery Clinical Outcomes Research Program

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.